Printer Friendly

Browse Biological products industry topic

Subtopics (139)

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
Hansa Biopharma signs contract with Sarepta Therapeutics. Jul 3, 2020 163
Hansa Biopharma signs contract with Sarepta Therapeutics. Jul 3, 2020 159
EC grants conditional marketing authorization for Gilead's Veklury for COVID-19. Jul 3, 2020 191
SK Biopharm hits daily ceiling on 1st trading day. Jul 2, 2020 1008
NuGenerex announces plans to address pandemic threat from swine flu virus. Jul 2, 2020 193
Remdesivir 'pricing debate' weighs on Celltrion. Jul 2, 2020 1034
FTSE 100 closes in red after volatile session as health fears weigh. Jul 2, 2020 4390
BioInvent International extends cancer immunotherapy research collaboration and license agreement term with Pfizer. Jul 2, 2020 197
BioInvent International extends cancer immunotherapy research collaboration and license agreement term with Pfizer. Jul 2, 2020 193
U.S. is buying 90% of all doses Drug: WHO looking into implications of U.S. deal. Maria Cheng AP Medical Writer Jul 2, 2020 649
Sarepta signs agreement with Hansa Biopharma for imlifidase. Jul 2, 2020 193
Humanigen reveals first patient has been infused in ZUMA-19 study. Jul 1, 2020 262
Matinas BioPharma commences enrollment and starts dosing in study of MAT9001 to treat cardiovascular and metabolic conditions. Jul 1, 2020 438
NA Proactive news snapshot: Milestone Scientific, BetterLife Pharma, Revive Therapeutics, Matinas BioPharma, Biocept UPDATE ... Jul 1, 2020 3673
No more free-lunch bailouts. Jul 1, 2020 1091
US strikes deal to secure almost all of the world's upcoming supply of remdesivir to treat COVID-19. Jul 1, 2020 152
US strikes deal to secure almost all of the world's upcoming supply of remdesivir to treat COVID-19. Jul 1, 2020 156
Sinovac Biotech Ltd incurs loss of USD7.4m for Q1 2020. Jul 1, 2020 195
Sinovac Biotech Ltd incurs loss of USD7.4m for Q1 2020. Jul 1, 2020 191
Sinovac Biotech Ltd incurs loss of USD7.4m for Q1 2020. Jul 1, 2020 193
TOP NEWS: US Buys Up Almost All Stocks Of Anti-Viral Drug Remdesivir. Jul 1, 2020 482
Qiagen Wins Shareholder Nod for Acquisition by Thermo Fisher Scientific. Jul 1, 2020 510
Qiagen Wins Shareholder Nod for Acquisition by Thermo Fisher Scientific. Jul 1, 2020 481
Meissa Vaccines Provides a Pipeline Update on Vaccine Candidates for COVID-19 and RSV. Jul 1, 2020 412
Gilead slaps multi-thousand-dollar price tag on coronavirus treatment remdesivir. Jun 30, 2020 330
Gilead's $2,340 price for coronavirus drug draws criticism. MARILYNN MARCHIONE AP Chief Medical Writer Jun 30, 2020 800
Can-Fite BioPharma announces final data from Namodenoson study. Jun 30, 2020 716
Seattle Genetics price target raised to $167 from $155 at SVB Leerink. Jun 30, 2020 168
Gilead slaps multi-thousand-dollar price tag on coronavirus treatment remdesivir. Jun 30, 2020 332
9 Meters Biopharma amends definition of primary endpoint for larazotide trial. Clinical report Jun 29, 2020 188
RedHill Biopharma receives approval for COVID-19 Phase 2/3 study with opaganib. Report Jun 29, 2020 222
FDA approves Genentech's Phesgo for HER2-positive breast cancer. Jun 29, 2020 208
Gilead Prices COVID-19 Drug Candidate Remdesivir At $2,340 Per Patient. Jun 29, 2020 377
Seattle Genetics reports 'positive' results from Phase 2 tisotumab vedotin trial. Financial report Jun 29, 2020 231
Helix BioPharma to divest its remaining shares in Polish subsidiary Helix Immuno-Oncology. Jun 27, 2020 452
Helix BioPharma to divest remaining ownership of Polish subsidiary. Jun 26, 2020 508
Vigt Nam gets closer to COVID-19 vaccine. Jun 26, 2020 555
COVID-19: Egypt's Rameda begins manufacturing Anviziram tablets to fight coronavirus. Samir Salama, Associate Editor Jun 25, 2020 438
Virus update. Jun 25, 2020 240
Theravance Biopharma says first COVID patient dosed in TD-0903 Phase 2 study. Jun 25, 2020 234
Frontier IP hails the progress of portfolio company The Vaccines Group. Jun 24, 2020 304
Stirling company to make virus vaccine; Symbiosis will supply trials. ALASTAIR MCNEILL Jun 24, 2020 420
Alexion SchrA[pilcrow sign]dinger Expands Discovery Efforts for COVID-19 Therapeutics. Jun 24, 2020 443
RedHill Biopharma announces publication of data from COVID-19 patients. Jun 24, 2020 374
Qiagen To Gain Possible USD120 Million From Invitae's ArcherDX Buy. Jun 24, 2020 164
Gilead Sciences to Acquire 49.9% Equity in Pionyr for USD 275m. Jun 24, 2020 199
Gilead Sciences to Acquire 49.9% Equity in Pionyr for USD 275m. Jun 24, 2020 230
Coronavirus: UK to trial saliva tests for asymptomatic cases, Evan Bioscences' candidate enters Cambridge trial, R factor rises in Germany... Jun 23, 2020 472
Pfizer Starts Four Phase 3 Clinical Trials for Investigational Vaccines. Jun 23, 2020 673
Schrodinger announces expansion of work to discover therapeutics for COVID-19. Jun 23, 2020 307
Palatin to develop PL8177 as a treatment for COVID-19 patients. Jun 23, 2020 187
Merck concludes acquisition of Themis as part of commitment to accelerate SARS-CoV-2 vaccine programme. Jun 22, 2020 206
Merck concludes acquisition of Themis as part of commitment to accelerate SARS-CoV-2 vaccine programme. Jun 22, 2020 210
Seattle Genetics Initiates Phase 1 Clinical Trials for Two Novel Antibody-Based Drug Candidates. Jun 22, 2020 523
Sutro Biopharma presents new data on STRO-002. Jun 22, 2020 235
Pfizer announces initiation of four Phase 3 investigational vaccine studies. Jun 22, 2020 153
Affimed N.V. announces presentation of data on Genentech's RO7297089. Jun 22, 2020 382
Gilead to start human testing of inhaled version of remdesivir. Jun 22, 2020 309
Merck & Co Seals Buy Of Covid-19 Vaccine Developer Themis. Jun 22, 2020 171
Genentech says Phase III IPATential150 study met co-primary endpoint. Jun 19, 2020 157
Merck Closes Acquisition of Vaccine Developer Themis. Jun 19, 2020 292
Merck Closes Acquisition of Vaccine Developer Themis. Jun 19, 2020 318
Mylan Wins US Court Decision In Tecfidera Patent Dispute With Biogen. Jun 19, 2020 282
BHP appoints CFO of Australian biotech as new finance boss. Jun 18, 2020 350
Biotech companies to dominate at Proactive One2One Virtual Investor Forum on June 23. Jun 18, 2020 1225
This Dh2.1 million watch is a tribute to the Bugatti Chiron SS 300+. Sony Thomas, wheels Editor Jun 18, 2020 328
Gilead Upping Focus On How Remdesivir Can Help Pediatric Patients. Jun 18, 2020 204
Genentech says Phase III IMpassion031 study met primary endpoint. Jun 18, 2020 242
Raymond James says Mylan win over Biogen has 'no real apparent financial upside'. Jun 18, 2020 161
Mylan wins District Court decision against Biogen's Tecfidera patent. Jun 18, 2020 230
Biotech companies to dominate at Proactive One2One Virtual Investor Forum on June 23. Jun 18, 2020 1223
IMPERIAL COLLEGE / UK BEGINS CORONAVIRUS VACCINE TRIAL; FRANCE PLEDGES FUNDING. Jun 17, 2020 862
Humanigen says lenzilumab drug delivers better recovery time for coronavirus-associated pneumonia in cross-trial analysis. Jun 17, 2020 365
TransCelerate Expands COVID-19 Clinical Trial Data Sharing to Include All Biopharma Companies and BioMedical Research Institutions. Jun 17, 2020 400
Vyripharm Biopharmaceuticals and Regis Technologies Ink Master Drug Program Agreement for Expediting cGMP Manufacture of Antiviral Agents for Diagnostic Evaluation of COVID-19. Jun 17, 2020 330
TOP NEWS: BHP Picks CSL Finance Chief David Lamont As New CFO. Jun 17, 2020 247
Open Orphan investee company showcases mosquito vaccine results in Lancet. Jun 16, 2020 353
Sinovac Touts Positive Preliminary Results of Phase I/II Clinical Trials for Inactivated Vaccine Candidate Against COVID-19. Jun 16, 2020 505
Dr. Reddy's Laboratories enters into a Licensing Agreement with Gilead Sciences for Remdesivir. Jun 16, 2020 219
Cue Biopharma says enrollment remains on schedule in Phase 1 trial of CUE-101. Jun 15, 2020 452
DOST wants local pharmas to make COVID vaccine. Jun 15, 2020 445
Sinovac Biotech in China reports its experimental COVID-19 vaccine induces antibodies. Jun 15, 2020 241
Sinovac Biotech in China reports its experimental COVID-19 vaccine induces antibodies. Jun 15, 2020 245
Fly Intel: Top five weekend stock stories. Jun 14, 2020 484
Genghis Capital, EGM Securities enable clients trade globally. Jun 13, 2020 354
157% price spike: $1,187 for each vial of COVID drug in India? Jay Hilotin, Assistant Editor Jun 11, 2020 1347
157% price spike: $1,187 for each vial of COVID-19 drug in India? Jay Hilotin, Assistant Editor Jun 11, 2020 1347
Moderna expects to begin Phase Phase 3 study of COVID-19 vaccine in July. Jun 11, 2020 246
Moderna Advances Late-Stage Development of its Vaccine Against COVID-19. Jun 11, 2020 874
China's Sinovac Inks Deal with Brazil's Butantan for the Clinical Development of An Inactivated Vaccine for COVID-19 to Phase III. Jun 11, 2020 590
Dyadic and Frederick National Laboratory to develop C1 cell lines for coronavirus vaccine candidates. Jun 11, 2020 760
Honeywell expedites production of vital vaccines. Jun 10, 2020 450
Singapore's HSA approves Gilead's remdesivir for COVID-19 treatment. Jun 10, 2020 192
RedHill Biopharma submits COVID-19 CTA for Phase 2/3 study of opaganib. Clinical report Jun 10, 2020 344
Biogen announces new results form NURTURE study in SMA. Jun 10, 2020 371
DelMar Pharmaceuticals to acquire Adgero Biopharmaceuticals in-all equity deal. Jun 10, 2020 242
Singapore approves remdesivir drug for emergency COVID-19 treatment. Reuters News Service Jun 10, 2020 264
Gilead's remdesivir shows promise in Covid-19 study on monkeys. Clinical report Jun 9, 2020 308
IATF OKs Sinovac as PH's potential collaborator for COVID-19 vaccine dev't. Jun 9, 2020 287
PHL to join Sinovac clinical trials for Covid-19 vaccine. Jun 9, 2020 373
Chinese biopharm firm among PH's collaborators to develop COVID-19 vaccine. Jun 9, 2020 295
LONDON BRIEFING: RWS And City Of London Investment Group Get M&A Going. Jun 9, 2020 1535
Biolog-id Teams with Lifeshare Blood Center to Combat Covid-19. Jun 9, 2020 272
AstraZeneca cools speculation over merger with Gilead Sciences. Jun 9, 2020 348
AstraZeneca and Gilead Sciences merger hard to square say analysts. Jun 9, 2020 540
AstraZeneca cools speculation over merger with Gilead Sciences. Jun 9, 2020 350
Morning Report: FTSE 100 eases lower as travel quarantine rules come into force in UK. Jun 9, 2020 377
AstraZeneca and Gilead Sciences merger hard to square say analysts. Jun 9, 2020 542
FTSE 100 closes in red after quiet session and excitement after Friday's jobs report wears off. Jun 9, 2020 3854
BioPharma Services Relocates US Clinic Facility Due to Covid-19. Jun 8, 2020 297
US government's supply of COVID-19 drug remdesivir likely to run out. Jun 8, 2020 216
CEPI and CSL to advance development and manufacture of UQ molecular clamp COVID-19 vaccine candidate. Jun 8, 2020 229
US government's supply of COVID-19 drug remdesivir likely to run out. Jun 8, 2020 220
CEPI and CSL to advance development and manufacture of UQ molecular clamp COVID-19 vaccine candidate. Jun 8, 2020 233
PRESS: AstraZeneca-Gilead Merger Speculation Dampened - Telegraph. Jun 8, 2020 178
LONDON MARKET EARLY CALL: Stocks Seen Lower; AstraZeneca In Focus. Jun 8, 2020 672
Gilead shares worth at least $120 in takeover by AstraZeneca, says Piper Jaffray. Jun 8, 2020 174
Citi sees low probability of AstraZeneca acquiring Gilead. Jun 8, 2020 157
COVID-19 drugs from India, Pakista, Bangladesh: Remdesivir, camostat, avipiravir, HQC and others. Jay Hilotin, Assistant Editor Jun 7, 2020 2288
Fly Intel: Top five weekend stock stories. Jun 7, 2020 474
Baguio nurse joins WHO trials for COVID-19 treatment. Jun 6, 2020 210
HC Wainwright's Raghuram Selvaraju says Tiziana Life Sciences PLC worth US$25 a share; Alzheimer's represents "massive market". Jun 6, 2020 539
HC Wainwright's Raghuram Selvaraju says Tiziana Life Sciences PLC worth US$25 a share; Alzheimer's represents "massive market". Jun 6, 2020 537
Espero BioPharma expands tecarfarin collaborative partnering effort. Jun 5, 2020 179
Filgotinib Demonstrates Durable Efficacy and Consistent Safety Profile at 52 Weeks in FINCH 1 and 3 Studies in Rheumatoid Arthritis. Jun 5, 2020 328
Espero BioPharma expands tecarfarin collaborative partnering effort. Jun 5, 2020 183
Pakistani industry needs to do research to fight epidemics. Jun 5, 2020 376
Business expert predicts great future for Taiwan's cybersecurity sector. Jun 5, 2020 218
Egypt to soon use anti-viral Remdesivir in coronavirus treatment: official. Egypt Today staff Jun 4, 2020 320
Gilead, Galapagos announce Week 52 results from Phase 3 FINCH 1, FINCH 3 studies. Jun 4, 2020 153
Can-Fite BioPharma concludes meeting with EMA on Phase 3 Namodenoson development. Jun 4, 2020 253
Biogen presents Phase 2 cutaneous lupus erythematosus data. Jun 4, 2020 379
AGC Biologics collaborates with Novavax for NVX-CoV2373 production. Jun 4, 2020 169
AGC Biologics collaborates with Novavax for NVX-CoV2373 production. Jun 4, 2020 165
Gilead Sciences' remdesivir shows improvement in coronavirus patients with moderate pneumonia. Jun 3, 2020 218
Sumitovant Biopharma announces Myovant Sciences' US FDA New Drug Application submission for once-daily Relugolix Combination Tablet for the treatment of women with uterine fibroids. Jun 3, 2020 280
Sumitovant Biopharma announces Myovant Sciences' US FDA New Drug Application submission for once-daily Relugolix Combination Tablet for the treatment of women with uterine fibroids. Jun 3, 2020 284
Gilead Sciences' remdesivir shows improvement in coronavirus patients with moderate pneumonia. Jun 3, 2020 216
Vault Pharma Launches Coronavirus Vaccine Development. Jun 2, 2020 615
Longhorn Vaccines and Diagnostics, Cenetron Diagnostics Team up with Coca-Cola Bottlers to Produce COVID-19 Test Kits. Jun 2, 2020 467
Gilead Shows Results from Phase 3 Trial of Remdesivir in Patients with Moderate COVID-19. Jun 2, 2020 892
Gilead says remdesivir helped moderate Covid-19 patients improve. Reuters News Service Jun 1, 2020 246
Remdesivir now proven effective for COVID-19 in three studies, says Piper. Jun 1, 2020 161
Twist Bioscience to Join Proteona in Global Alliance to Protect Immunocompromised Patients From COVID-19 Infection. Jun 1, 2020 641
Ligand working with Gilead to meet need for remdesivir. Jun 1, 2020 410
CTI BioPharma Enrolls 1st Patient in COVID-19 PRE-VENT Trial. Clinical report Jun 1, 2020 209
COVID-19 mRNA vaccine: Will it save the world? Here's what you need to know. Jay Hilotin, Assistant Editor May 31, 2020 1253
Pakistan Will Soon Start Production of the Antiviral Drug Remdesivir. May 31, 2020 308
Coronavirus: Pakistan's pharma firm to import potential treatment from Bangladesh. May 30, 2020 338
Pakistan to import remdesivir from Bangladesh. May 29, 2020 305
Pakistan to import potential Covid-19 treatment from Bangladesh. May 29, 2020 357
Gilead Sciences, Roche to study remdesivir/Actemra combination in coronavirus patients. May 29, 2020 232
Industry will leave no one behind on virus vaccine. May 29, 2020 301
Genocea presents updated long-term data from GEN-009 Phase 1/2a trial. May 29, 2020 335
Vir Biotechnology, Biogen enter agreement to manufacture SARS-CoV-2 antibodies. May 29, 2020 215
Seattle Genetics announces results from exploratory analyses of HER2CLIMB trial. Financial report May 29, 2020 232
FDA approves Genentech's Tecentriq in combination with Avastin. May 29, 2020 222
Gilead Sciences, Roche to study remdesivir/Actemra combination in coronavirus patients. May 29, 2020 230
Genentech Starts Phase III Clinical Trial of Actemra Plus Remdesivir in Hospitalized Patients with Severe COVID-19 Pneumonia. May 28, 2020 1016
Roche, Gilead To Test Drug Cocktail Against Severe Covid-19. May 28, 2020 345
Genentech, Gilead initiate Phase III clinical trial of Actemra plus remdesivir. May 28, 2020 340
ARCA Biopharma announces AB201 development program for coagulopathy. May 28, 2020 554
Open Orphan broker kicks off coverage with 19p a share price target. May 27, 2020 222
Gilead Sciences' remdesivir to be available for selected Covid-19 patients in the UK. May 27, 2020 217
Doctors prescribing Ebola drug to patients with 'severe' infection; HEALTH. JANE KIRBY May 27, 2020 241
SUFFERERS' DRUG BOOST; CORONAVIRUS CRISIS: FRESH HOPE AMID PANIC>>Ebola drug cleared for use on Covid-19>>Hancock hails 'biggest step' in our battle. MARTIN BAGOT Health Editor May 27, 2020 681
11 vaccine giants: How they're fighting COVID-19. Jay Hilotin, Assistant Editor May 27, 2020 1119
NYSE floor opens, stocks surge Markets: New home sales, consumer confidence both up. Thomas Heath and Taylor Telford The Washington Post May 27, 2020 651
CSL Leases Swiss Biotechnology Manufacturing Facility To Thermo Fisher. May 27, 2020 236
Genentech says Phase III Archway study met primary endpoint. May 27, 2020 232
RedHill Biopharma reports Q1 EPS (5c), consenus (24c). Financial report May 27, 2020 304
RedHill Biopharma expects initiation of Phase 3 study of RHB-204 in Q3. May 27, 2020 325
RedHill Biopharma aims to enroll up to 40 patients in Phase 2a study of opaganib. Clinical report May 27, 2020 184
RedHill Biopharma plans to add third arm to Phase 2a study of opaganib. May 27, 2020 190
Gilead, Arcus Biosciences establish 10-year cancer immunotherapies partnership. May 27, 2020 508
Gilead Sciences' remdesivir to be available for selected Covid-19 patients in the UK. May 27, 2020 215
BAFIERTAM RECEIVES FINAL FDA APPROVAL FOR MS. May 27, 2020 463
Selected UK patients within NHS to gain access to COVID-19 drug remdesivir. May 26, 2020 229
Selected UK patients within NHS to gain access to COVID-19 drug remdesivir. May 26, 2020 225
US Merck to Acquire Vaccine Developer Themis. May 26, 2020 380
Merck to acquire Themis Bioscience, to collaborate with IAVI, Ridgeback Bio. May 26, 2020 337
US Merck to Acquire Vaccine Developer Themis. May 26, 2020 354
Pharma giant Merck enter coronavirus vaccine race with three treatments. Edward Thicknesse May 26, 2020 440
Philippines to take part in 2 Taiwanese clinical trails for coronavirus vaccine. May 25, 2020 451
DOH readies case vs Pinoy 'vaccine' maker. May 25, 2020 349
Sinovac Secures USD 15m in Funding to Accelerate COVID-19 Vaccine Development. May 22, 2020 495
Is a coronavirus vaccine harmful? May 22, 2020 1042
U.S. plans 'massive' vaccine testing with over 100,000 patients, Reuters says. May 22, 2020 168
UniPath announces availability of COVID-19 PCR and antibody testing for employers in Colorado. May 22, 2020 167
UniPath announces availability of COVID-19 PCR and antibody testing for employers in Colorado. May 22, 2020 171
Sutro Biopharma names new VP of Clinical Development and promotes Regina Cheng to VP of Finance and Controller. May 22, 2020 203
Sutro Biopharma names new VP of Clinical Development and promotes Regina Cheng to VP of Finance and Controller. May 22, 2020 207
COVID-19 vaccine clinical trials set in 2021. May 21, 2020 350
Early Vaccine Trial Results Raise Hopes And Stock Market. May 21, 2020 988
Global quandary over control of coronavirus vaccines and antiviral drugs. Cornelia Meyer May 21, 2020 974
Gilead's filgotinib likely being underestimated by Street, says Piper Sandler. May 21, 2020 155
Gilead Sciences Reports Topline Results from Filgotinib Trial. May 21, 2020 287
Pandion Therapeutics Names Sundy as Chief Medical Officer. May 20, 2020 282
Duterte readies funds to buy COVID-19 vaccine as soon as it is available. May 20, 2020 503
Strongbridge Biopharma announces $30M debt facility with Avenue. May 20, 2020 305
Enzo Biochem launches test for detection of SARS-CoV-2 IgG antibody. May 20, 2020 379
Galapagos, Gilead report Phase 2B/3 results from filgotinib study. May 20, 2020 168
Biogen announces new data from MS treatment portfolio. May 19, 2020 507
Cue Biopharma reports Q1 EPS (48c), consensus (35c). Financial report May 19, 2020 152
Hope for humanity as Covid-19 vaccine shows promising results in human trials. May 19, 2020 325
Thermo Fisher publishes offer document for voluntary tender offer for Qiagen. May 18, 2020 210
Can-Fite BioPharma reports additional findings from Phase II NASH study. Clinical report May 18, 2020 232
Biogen says new SPINRAZA data reinforce sustained efficacy, longer-term safety. Clinical report May 18, 2020 307
Cue Biopharma to present preclinical data on CUE-102/A02, CUE-102/A24. May 18, 2020 181
Experimental coronavirus vaccine based on tobacco could begin human trials next month; British American Tobacco's biotech subsidiary, Kentucky BioProcessing (KBP), uses tobacco plants to make the vaccine, which is derived from the genetic sequence of SARS-CoV-2. By, Shivali Best May 18, 2020 363
Biopharma Starts Collecting Plasma From Donors Recovered From Coronavirus. May 18, 2020 393
Remdesivir OK'd for COVID Patients. May 18, 2020 632
Pakistan gets license to make medicine for coronavirus patients: Dr Zafar. May 16, 2020 557
Pakistan gets license to make medicine for coronavirus patients: Dr Zafar. May 15, 2020 493
Gilead Sciences' remdesivir to be distributed in 127 countries. May 15, 2020 229
High Prevalence of Hepatitis C Infection Among Adult Patients at Four rban Emergency Departments--Birmingham, Oakland, Baltimore, and Boston, 2015-2017. Galbraith, James W.; Anderson, Erik S.; Hsieh, Yu-Hsiang; Franco, Ricardo A.; Donnelly, John P.; Rod May 15, 2020 4565
Sutro Biopharma raises USD98m in public offering. May 15, 2020 178
Transgene and BioInvent Present Preclinical Data Demonstrating BT-001's Powerful Activity Against Solid Tumors. May 15, 2020 715
Medicago Touts Positive Results in Animal Trials for Its Vaccine Candidate Against COVID-19. May 15, 2020 654
MorphoSys, Incyte See Encouraging Data From Long-Term L-MIND Study. May 15, 2020 185
Can-Fite BioPharma files pre-IND meeting request with FDA for Piclidenoson. May 15, 2020 177
Coronavirus vaccine taken by tablet instead of injection could soon be tested in humans; Dr Sean Tucker, chief scientific officer at Vaxart, has revealed that his company is trialling several vaccine tablets, which could be trailed in humans as early as July. By, Shivali Best & Ryan Merrifield May 15, 2020 356
Gilead Sciences' remdesivir to be distributed in 127 countries. May 15, 2020 227
Helix BioPharma announces data from L-DOS47 dose escalation study of non-small cell lung cancer patients. May 15, 2020 306
Cipla partners with Gilead to expand the access of Remdesivir to COVID-19. May 14, 2020 256
Hetero Enters Into a Licensing Agreement with Gilead for the Manufacturing and Distribution of "Remdesivir" in 127 Countries for COVID-19. May 14, 2020 328
Cipla partners with Gilead to expand the access of Remdesivir to COVID-19. May 14, 2020 254
Cipla partners with Gilead to expand the access of Remdesivir to COVID-19. May 14, 2020 258
Evox Therapeutics welcomes Paul Carter as non-executive chairman. May 14, 2020 153
Hetero to manufacture and distribute Remdesivir in 127 countries for treatment of COVID-19. May 14, 2020 151
Evox Therapeutics welcomes Paul Carter as non-executive chairman. May 14, 2020 155
Hetero to manufacture and distribute Remdesivir in 127 countries for treatment of COVID-19. May 14, 2020 153
MorphoSys announces long-term follow-up results from L-MIND study of tafasitamab. May 14, 2020 220
Artax Biopharma names new CEO. May 14, 2020 226
Veloce BioPharma reveals Halodine Antiseptics viricidal efficacy against COVID-19. May 14, 2020 156
Artax Biopharma names new CEO. May 14, 2020 222
Veloce BioPharma reveals Halodine Antiseptics viricidal efficacy against COVID-19. May 14, 2020 152
Pakistan firm to produce only effective drug against Covid-19. May 14, 2020 341
Ferozsons subsidiary inks agreement with Gilead for manufacturing 'experimental drug' remdesivir. May 13, 2020 425
Ferozsons concludes agreement with Gilead to produce Remdesivir. Ihsan Qadir May 13, 2020 269
Mylan to distribute investigational antiviral remdesivir for the potential treatment of COVID-19. May 13, 2020 189
Mylan to distribute investigational antiviral remdesivir for the potential treatment of COVID-19. May 13, 2020 185
Mylan to distribute investigational antiviral remdesivir for the potential treatment of COVID-19. May 13, 2020 187
Mylan Partners With Gilead Sciences For Remdesivir Distribution. May 13, 2020 235
COVID-19: CBN okays research grant for local vaccine production. May 13, 2020 582
Oncimmune agrees drug development collaboration with leading US biopharma group. May 13, 2020 292
Matinas BioPharma Holdings gets ready to restart clinical studies on MAT9001 and MAT2203 in June. Clinical report May 12, 2020 624
Sutro Biopharma prices USD85.3m public offering. May 12, 2020 216
Sutro Biopharma prices USD85.3m public offering. May 12, 2020 212
Mylan to Supply Investigational Antiviral Remdesivir for the Potential Treatment of COVID-19. May 12, 2020 433
Mylan to supply investigational antiviral remdesivir for COVID-19 treatment. May 12, 2020 169
Ferozsons in talks to produce Remdesivir. May 12, 2020 218
NA Proactive news snapshot:AaMatinas BioPharma Holdings, Marrone Bio Innovations, Zynerba Pharmaceuticals, BioPorto, Mawson Resources UPDATE ... May 12, 2020 4067
COVID-19: CBN to give grants to aid researchers produce local vaccines. May 12, 2020 1626
Stocks close flat amid lack of triggers. May 11, 2020 602
Arbutus Biopharma initiates program to find medicines to treat COVID-19. May 11, 2020 244
Soligenix announces RiVax immunogenicity studies published. May 11, 2020 252
Infinity Pharmaceuticals reports Q1 EPS (19c), consensus (13c). Financial report May 11, 2020 311
Inovio reports Q1 EPS (26c), consensus (22c). Financial report May 11, 2020 209
Stabilitech Biopharma working on a breakthrough coronavirus vaccine that can be taken in pill form. May 8, 2020 510
Mice administered with Vietnamese COVID-19 vaccine remain healthy. May 8, 2020 903
Ebola drug shown to work against coronavirus 'could cost up to $4,500 per treatment'; A consumer expert has called for remdesivir manufacturer Gilead Sciences to "fully disclose its research and development costs and all public contributions" if it plans to charge more than $1 a day for the treatment. By, Deena Beasley & Ryan Merrifield May 8, 2020 688
RedHill Biopharma gets FDA OK for COVID-19 clinical study with opaganib. May 8, 2020 294
ZYUS Collaborates with USask's VIDO-InterVac to Develop a Plant-Based Vaccine for COVID-19. May 8, 2020 277
Two local companies to manufacture 'Remdesivir'. May 8, 2020 355
ARCA Biopharma announces presentations of Gencaro clinical data. May 7, 2020 528
Japan Set To Approve Gilead's Remdesivir For Coronavirus Treatment. May 7, 2020 308
Japanese Ministry of Health Approves Veklury (remdesivir) in Japan for Patients with Severe COVID-19. May 7, 2020 485
Taiwanese COVID-19 vaccine still has hurdles to clear: CECC expert. May 6, 2020 267
First Animal Study Results of Sinovac Vaccine Against COVID-19 Published in Science. May 6, 2020 440
Gilead Sciences in talks with pharma companies in Pakistan, India to start remdesivir production. May 6, 2020 352
$4,460 for Remdesivir: Who owns it, where is it? Jay Hilotin, Assistant Editor May 6, 2020 1001
COVID-19 vaccine: $4,460 or $10 for a remdesivir shot, how much is fair price? Jay Hilotin, Assistant Editor May 6, 2020 1123
PDL BioPharma announces distribution in the form of a pro rata common stock dividend of shares of Evofem. May 6, 2020 187
PDL BioPharma announces distribution in the form of a pro rata common stock dividend of shares of Evofem. May 6, 2020 191
COVID-19 vaccine: $10 or $4,460 per emdesivir shot, how much is fair price? Jay Hilotin, Assistant Editor May 6, 2020 1174
COVID-19 vaccine: $10 or $4,460 per remdesivir shot, how much is fair price? Jay Hilotin, Assistant Editor May 6, 2020 1174
Gilead In Talks Over Remdesivir Production In Europe And Beyond. May 6, 2020 200
GLOBAL TOP NEWS SUMMARY: European PMIs At Historic Lows As Virus Bites. May 6, 2020 1777
CSL To Soon Start Development Of Plasma In Fight Against Covid-19. May 6, 2020 200
Strongbridge Biopharma reports Q1 adj. EPS (19c), consensus (22c). Financial report May 6, 2020 345
Strongbridge Biopharma expects results from LOGICS study in Q3. Clinical report May 6, 2020 161
Taiwan's coronavirus vaccine proven effective on animal subjects. May 5, 2020 232
Gilead Sciences' remdesivir receives US emergency approval for coronavirus treatment. May 5, 2020 241
Stabilitech Biopharma to take its 'revolutionary' COVID-19 vaccine capsule into the clinic. May 5, 2020 152
Enteris BioPharma elects Rajiv Khosla, PhD as CEO. May 5, 2020 199
Enteris BioPharma elects Rajiv Khosla, PhD as CEO. May 5, 2020 195
RedHill Biopharma announces publication of results of Phase 3 study of Talicia. May 5, 2020 357
Combating coronavirus: Dh50 vaccine by July? Indian major puts its money where its mouth is. Allan Jacob May 5, 2020 698
Gilead Sciences' remdesivir receives US emergency approval for coronavirus treatment. May 5, 2020 239
Gilead CEO Says Remdesivir Will Be Available To Treat Coronavirus Patients In US This Week. May 4, 2020 488
Arcturus Therapeutics, Catalent Team to Manufacture mRNA-Based COVID-19 Vaccine. May 4, 2020 248
The FDA awards Emergency Use Authorization for antiviral drug remdesivir for potential treatment of COVID-19. May 4, 2020 202
The FDA awards Emergency Use Authorization for antiviral drug remdesivir for potential treatment of COVID-19. May 4, 2020 204
The FDA awards Emergency Use Authorization for antiviral drug remdesivir for potential treatment of COVID-19. May 4, 2020 200
Remdesivir given 'fairly lax' treatment requirements, say Piper Sandler. May 4, 2020 164
IND Application To FDA For COVID-19 Stem Cell Therapy. May 4, 2020 163
Gilead CEO says remdesivir will get to patients early this week. May 3, 2020 163
US Gilead to provide FDA-approved coronavirus treatment on Monday. Sarah El-Sheikh May 2, 2020 397
Egypt contracts with Gilead to get remdesivir drug for COVID-19 patients. Egypt Today staff May 2, 2020 283

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters